CAMIT DIABETES MANAGEMENT SOFTWARE

K001907 · Roche Diagnostics Corp. · CGA · Sep 5, 2000 · Clinical Chemistry

Device Facts

Record IDK001907
Device NameCAMIT DIABETES MANAGEMENT SOFTWARE
ApplicantRoche Diagnostics Corp.
Product CodeCGA · Clinical Chemistry
Decision DateSep 5, 2000
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 862.1345
Device ClassClass 2

Regulatory Classification

Identification

A glucose test system is a device intended to measure glucose quantitatively in blood and other body fluids. Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, and idiopathic hypoglycemia, and of pancreatic islet cell carcinoma.

Special Controls

*Classification.* Class II (special controls). The device, when it is solely intended for use as a drink to test glucose tolerance, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.

Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...